This is a working overview of heptapeptide, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-26 and is reviewed periodically as new material appears.
Reported pharmacological work centers on neurotrophic signaling, including changes in BDNF and NGF expression in hippocampal tissue in animal models. Human data come largely from studies conducted in Russia, and how well those results generalize to other populations remains an open question. Regulatory status differs sharply by jurisdiction: Semax is a registered prescription medicine in Russia, while it holds no approved marketing status in the United States or the European Union. Outside such jurisdictions it is generally handled as a research chemical, which affects both documentation and quality expectations.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed as a fragment analog of adrenocorticotropic hormone, modeled specifically on the ACTH(4-10) region. The first four residues reproduce that fragment, while a Pro-Gly-Pro tripeptide is appended at the C-terminus. Work on the compound originated in Russia, where it entered clinical use as an intranasal preparation. Its sequence places it among short regulatory peptides studied for effects on the central nervous system rather than on the adrenal axis.
Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.
The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.
| Property | Value | Notes |
|---|---|---|
| Molecular weight | ~813.9 Da (free heptapeptide) | N-acetylated form is about 42 Da heavier |
| Residue count | 7 (heptapeptide) | Four residues from ACTH(4-10), three added |
| Appearance | White to off-white powder | Usually supplied lyophilized |
| Solubility class | Freely soluble in water | Also dissolves in DMSO and polar organic solvents |
| Related parent fragment | ACTH(4-10) | Parent motif is Met-Glu-His-Phe |
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
Pharmacological accounts link semax to melanocortin signalling and to modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor and nerve growth factor. Much of this evidence comes from rodent studies using intranasal delivery, a route chosen because it allows peptides to reach the central nervous system with limited systemic exposure. Whether the same mechanisms operate in humans at comparable magnitude remains an open question. The precise receptor or receptors responsible for the reported behavioural and neuroprotective effects have not been conclusively identified.
Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.
Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its chain combines the first seven residues of corticotropin with a C-terminal proline-glycine-proline extension, a modification intended to slow enzymatic breakdown. The free peptide has a molecular mass near 813.9 daltons. It belongs to the class of ACTH-derived fragments studied for central nervous system activity rather than for adrenal steroid stimulation. This structural relationship to a natural hormone fragment is the usual starting point for describing the compound in the literature.
Development took place during the 1980s at institutes of the Russian Academy of Sciences, where peptide fragments of ACTH were screened for cognitive and neuroprotective effects. The compound received regulatory approval in Russia as a nasal preparation, marketed for conditions such as ischemic stroke, transient ischemic attacks, and optic nerve disorders. Registration in other countries has not followed. Most published clinical reports originate from a small number of Russian research groups, and independent replication outside that setting remains limited. The regulatory status therefore differs sharply between Russia and the rest of the world.
In early 2008, Carrier acquired Environmental Market Solutions, Inc. (EMSI), an environmental and green building consulting company based in the United States. The company has received Leadership in Energy and Environmental Design (LEED) certification from the US Green Building Council for its factories in Charlotte, NC, and Huntington, IN (2009), Shanghai, China (2010), and Monterrey, Mexico (2011). In September 2013, Carrier, Otis, and United Technologies Fire and Security were combined into one subsidiary, UTC Building & Industrial Systems. In 2016, Otis was split off, with the remainder becoming UTC Climate, Controls & Security. In January 2016, Carrier announced it would lay off an unspecified number of employees at its research and development division in the town of DeWitt, New York. In February 2016, Carrier announced it would close its Indianapolis factory and move production to Monterrey, Mexico. HVAC Systems and Services North America president Chris Nelson cited "ongoing cost and pricing pressures" and Carrier's "existing infrastructure and a strong supplier base" in Mexico, saying that the move would allow the company "to operate more cost-effectively." The Carrier spokesperson told the crowd that there would be no immediate impact on jobs, that the move would take place over three years, and no jobs would be affected until mid-2017, with the move to be completed by the end of 2019.
=== Hanging flowers in ventilated area === There are several air-drying methods used for different kinds of flowers. The easiest and most effective way to dry most flowers is to tie them in small bundles with twine, raffia or ribbons, and hang them upside down, out of direct sunlight in a warm, well-ventilated place. Bunches should contain one type of flower. Large flowers are dried individually. The leaves stripped as soon as possible after picking. They retain moisture and slow down the drying process. Wall hooks, poles or wires are placed at least 15 centimetres (6 in) from the ceiling. Heads should be staggered to allow plenty of air to circulate. This prevents mildew and rot. It may be necessary to re-tie bunches or individual flowers half way through the drying process, because the stems tend to shrink as they dry. The drying period can range from one week to several weeks depending on the type of material, when and where it was harvested and the humidity of the place where it is drying. The stems of hung flowers tend to dry unnaturally straight and the flowers become very brittle. Suggested flowers to air dry include: strawflowers, goldenrod, Hydrangeas, Celosia (crested and plumed types), globe amaranth, Salvia, Xeranthemum and many of the "everlastings."
=== Relationship to land plants === Fossils of isolated spores suggest land plants may have been around as long as 475 million years ago (mya) during the Late Cambrian/Early Ordovician period, from sessile shallow freshwater charophyte algae much like Chara, which likely got stranded ashore when riverine/lacustrine water levels dropped during dry seasons. These charophyte algae probably already developed filamentous thalli and holdfasts that superficially resembled plant stems and roots, and probably had an isomorphic alternation of generations. They perhaps evolved some 850 mya and might even be as early as 1 Gya during the late phase of the Boring Billion.
=== Colored particles === In principle, any colored particle can be used, but latex (blue color) or nanometer-sized particles of gold (red color) are most commonly used. The gold particles are red in color due to localized surface plasmon resonance. Fluorescent or magnetic labelled particles can also be used, but these require the use of an electronic reader to assess the test result.
This cascade results in decreased cell motility opposing to IGF-1 - dependent mechanism. Loss of IRS-1 expression and PTEN mutations in LNCaP cells could promote metastasis. Ex vivo studies of IRS-1 involvement in prostate cancer show ambiguous results. Down-regulation of IGF1R in bone marrow biopsies of metastatic prostate cancer goes along with down-regulation of IRS-1 and significant reduction of PTEN in 3 out of 12 cases. Most of the tumors still express IRS-1 and IGF1R during progression of the metastatic disease. IRS-1 has a functional role in breast cancer progression and metastasis. Overexpression of PTEN in MCF-7 epithelial breast cancer cells inhibits cell growth by inhibiting MAPK pathway. ERK phosphorylation through IRS-1/Grb-2/Sos pathway is inhibited by phosphatase activity of PTEN. PTEN does not have effect on IRS-1 independent MAPK activation. When treated with insulin, ectopic expression of PTEN in MCF-7 suppresses IRS-1/Grb-2/Sos complex formation due to differential phosphorylation of IRS-1. Overexpression of IRS-1 has been linked to antiestrogen resistance and hormone independence in breast cancer. Tamoxifen (TAM) inhibits IRS-1 function, therefore suppressing IRS-1/PI3K signalling cascade in estrogen receptor positive (ER+) MCF-7 cell line. IRS-1 siRNA is able to reduce IRS-1 transcript level, thereby reducing protein expression in MCF-7 ER+ cells. Reduction of IRS-1 leads to decreased survival of these cells. siRNA treatment effects are additive to effects of TAM treatment.
Sources: en.wikipedia.org
Copper alloy surfaces have intrinsic properties to destroy a wide range of microorganisms. The US Environmental Protection Agency (EPA), which oversees the regulation of antimicrobial agents and materials in that country, found that copper alloys kill more than 99.9% of disease-causing bacteria within just two hours when cleaned regularly. Copper and copper alloys are unique classes of solid materials as no other solid touch surfaces have permission in the U.S. to make human health claims (EPA public health registrations were previously restricted only to liquid and gaseous products). The EPA has granted antimicrobial registration status to 355 different copper alloy compositions. In healthcare applications, EPA-approved antimicrobial copper products include bedrails, handrails, over-bed tables, sinks, faucets, door knobs, toilet hardware, intravenous poles, computer keyboards, etc. In public facility applications, EPA-approved antimicrobial copper products include health club equipment, elevator equipment, shopping cart handles, etc. In residential building applications, EPA-approved antimicrobial copper products include kitchen surfaces, bedrails, footboards, door push plates, towel bars, toilet hardware, wall tiles, etc. In mass transit facilities, EPA-approved antimicrobial copper products include handrails, stair rails grab bars, chairs, benches, etc.
Little Caesars produces a variety of pizzas. Several core menu items are part of the HOT-N-READY menu, designed to make popular items available for immediate carry-out, while others are considered either specialty pizzas or custom pizzas. In 2013, they added the Deep! Deep! Dish Pizza, a Detroit-style pizza, to the menu. Additional entrée options include flavored Caesar Wings and bread, such as Crazy Bread and Italian Cheese Bread. Select locations offer salads. All Little Caesars locations carry Pepsi products. Little Caesars also sells brownies. In 1996, they introduced Pizza by the Foot, a three-foot-long rectangular pizza. The product has since been discontinued; however, its equivalent, Pizza by the Meter, has been sold in the Saudi Arabian market since the 90s and is a top-rated product. On occasion, Little Caesars releases limited time offers. In 2014, they introduced the Soft Pretzel Crust Pizza, and in 2015, the "Bacon Wrapped Deep! Deep! Dish Pizza." In May 2019, Little Caesars began testing a pizza with meatless sausage made by Impossible Foods. In June 2020, Little Caesars reintroduced Stuffed Crazy Bread. They first introduced it in 1995. The original Crazy Bread was first introduced in 1982. As of May 15, 2023, Little Caesars introduced Crazy Puffs in Canada as a handheld snack made with pizza dough filled with cheese, pepperoni, and sauce, topped with garlic sauce and herbs. They later launched in the U.S. on March 11, 2024, offering both pepperoni and cheese varieties.
== SC == sc – (s) Sardinian language (ISO 639-1 code) Sc – (s) Scandium SC (s) Cruiser Submarine (US Navy hull classification) c Saint Kitts and Nevis (FIPS 10-4 country code; from Saint Christopher) Seychelles (ISO 3166 digram) South Carolina (postal symbol) SCA (i) Service Contract Act Sexual Compulsives Anonymous Society for Creative Anachronism SCAP – (a) Supreme Commander Allied Powers (Allied occupation of Japan) sccm – (s) Standard cubic centimetre per minute (unit of measurement of fluid flow) sccs – (s) Standard cubic centimetre per second (unit of measurement of fluid flow) scfh – (s) Standard cubic foot per hour (unit of measurement of fluid flow) scfm – (s) Standard cubic foot per minute (unit of measurement of fluid flow) scfs – (s) Standard cubic foot per second (unit of measurement of fluid flow) SCG – (s) Serbia and Montenegro (ISO 3166 trigram; defunct since 2006) SCHIMS – (i) Soldier Combat Helmet Identification Marking System SCHIP – (a) State Children's Health Insurance Program (U.S.; often pronounced "ess-chip") SciFi – Science Fiction sCJD – (i) Sporadic Creutzfeldt–Jakob disease SCM – (i) Surface Contamination Module SCMODS – (s) State, County, Municipal Offender Data System SCN – (p) Suprachiasmatic Nucleus SCNT – (i) Somatic Cell Nuclear Transfer SCO (i) Santa Cruz Operation (initials later used by SCO Group) (s) Scotland (FIFA trigram; not eligible for an ISO 3166 or IOC trigram) (a) Shanghai Cooperation Organisation SCOTUS – (a) Supreme Court of the United States SCR – (s) Seychelles rupee (ISO 4217 currency code) SCRAM – (a) Safety Control Rod Axe Man SCS (i) Scan Correlated Shift Soil Conservation Service SCSI (a) Small Computer System Interface ("scuzzy") (i) Strategic and Combat Studies Institute SCT – (s) Scattered Sky (METAR Code) SCTP – (i) Stream Control Transmission Protocol Scuba – (a) Self Contained Underwater Breathing Apparatus SCUF – Slow Continuous Ultrafiltration SCUFN – (i) Sub-Committee on Undersea Feature Names (of GEBCO)
SJIA is diagnosed clinically and corroborated by typical test findings; it is a diagnosis of exclusion. A child suspected of having sJIA should undergo a full evaluation for infection and cancer, including blood and urine cultures, imaging tests, and bone marrow exams to rule out leukemia or lymphoma. The International League of Associations for Rheumatology criteria for sJIA include arthritis, ≥2 weeks of daily fever, and symptoms like organomegaly, lymphadenopathy, serositis, or non-fixed/evanescent rash. Laboratory abnormalities are typical, but no specific tests are available for sJIA. Treatment for a disease varies greatly, requiring consideration of involvement, systemic characteristics, and MAS presence. Nonsteroidal anti-inflammatory medications can be safely administered for analgesic and antipyretic effects without altering initial diagnostic assessment results. Clinical trials show that anti-interleukin-6 and anti-interleukin-1 drugs are effective in managing systemic symptoms. Studies show that 40% of children with SJIA have a monocyclic disease history, recovering after varying periods. A small percentage experience a polycyclic course, with over half having a prolonged disease course. Juvenile idiopathic arthritis (JIA) is the most prevalent rheumatic illness in children, affecting 1 to 4 out of every 1000. SJIA accounts for 10% to 20% of cases, with peak presentation between 1 and 5 years. Children of all genders and ethnic origins are equally affected.
Sources: en.wikipedia.org
=== Pharmacokinetics === Exposure to radioactive waste may cause health impacts due to ionizing radiation exposure. In humans, a dose of 1 sievert carries a 5.5% risk of developing cancer, and regulatory agencies assume the risk is linearly proportional to dose even for low doses. Ionizing radiation can cause deletions in chromosomes. If a developing organism such as a fetus is irradiated, it is possible a birth defect may be induced, but it is unlikely this defect will be in a gamete or a gamete-forming cell. The incidence of radiation-induced mutations in humans is small, as in most mammals, because of natural cellular-repair mechanisms, many just now coming to light. These mechanisms range from DNA, mRNA and protein repair, to internal lysosomic digestion of defective proteins, and even induced cell suicide—apoptosis Depending on the decay mode and the pharmacokinetics of an element (how the body processes it and how quickly), the threat due to exposure to a given activity of a radioisotope will differ. For instance, iodine-131 is a short-lived beta and gamma emitter, but because it concentrates in the thyroid gland, it is more able to cause injury than caesium-137 which, being water soluble, is rapidly excreted through urine. In a similar way, the alpha emitting actinides and radium are considered very harmful as they tend to have long biological half-lives and their radiation has a high relative biological effectiveness, making it far more damaging to tissues per amount of energy deposited.
=== Allatostatin A === Allatostatin A (AstA) peptides are found in all arthropods and contain a C-terminus Y/FXFGLamide. In Drosophila, there are 4 AstA peptides (AstA-1, AstA-2, AstA-3, AstA-4) and 2 AstA receptors (AstA-R1 and AstA-R2). The AstA receptor is a GIRK1 channel and is homologous to the mammalian galanin receptor
In Virus (2019), directed by Aashiq Abu, Kallingal played nurse Akhila, a character based on Lini Puthussery — the nurse who died treating Kerala's first patient in the 2018 Nipah virus outbreak. Lini Puthussery's husband, who attended a screening of the film, said that Kallingal's portrayal was faithful and delivered "a flawless performance as Lini". Kallingal co-produced the film with Aashiq Abu under their production banner OPM Cinemas. Sowmya Rajendran described her performance as "expressive". In the 2021 film Santhoshathinte Onnam Rahasyam, directed by Don Palathara, Kallingal played an entertainment journalist opposite Jitin Puthenchery. Baradwaj Rangan described her performance as "terrific". The film won her Best Actress at the Diorama International Film Festival. In 2023 she appeared in Neelavelicham, a horror drama co-produced with Aashiq Abu. In 2025, Kallingal starred in Theatre, written and directed by Sajin Baabu, playing Meera, a woman who has lived an isolated life on a coastal Kerala island alongside her elderly mother. The film explores the conflict between traditional belief and modern science. The film had its world premiere at the Eurasian Bridge International Film Festival in Yalta on 9 October 2025, before its theatrical release on 16 October 2025. The role was physically demanding; director Sajin Baabu noted that Kallingal spent several hours atop a coconut tree for a single scene and completed multiple retakes despite sustaining bruises.
=== Organic electronics === A semiconducting polymer (poly(3-hexylthiophene) placed on top of single-layer graphene vertically conducts electric charge better than on a thin layer of silicon. A 50 nm thick polymer film conducted charge about 50 times better than a 10 nm thick film, potentially because the former consists of a mosaic of variably-oriented crystallites forms a continuous pathway of interconnected crystals. In a thin film or on silicon, plate-like crystallites are oriented parallel to the graphene layer. Uses include solar cells.
Pancreatic secretory trypsin inhibitor (PSTI) also known as serine protease inhibitor Kazal-type 1 (SPINK1) or tumor-associated trypsin inhibitor (TATI) is a protein that in humans is encoded by the SPINK1 gene. In the context of rat biology, it is also sometimes called monitor peptide.
Sources: en.wikipedia.org
The sequence is Met-Glu-His-Phe-Pro-Gly-Pro, a seven-residue peptide. The first four residues correspond to the ACTH(4-10) fragment, and Pro-Gly-Pro is added at the C-terminus. N-acetylated versions also appear in the literature and differ in mass.
Semax is a synthetic analog of the ACTH(4-10) fragment rather than a copy of the full hormone. Truncation plus the added tail removes the steroidogenic portion of ACTH. That distinction explains why it is studied for nervous-system effects instead of adrenal stimulation.
It is registered as a prescription product in Russia and has been used there clinically, chiefly by the intranasal route. No approval exists in the United States or the European Union. Availability elsewhere typically falls under research-chemical distribution, with varying purity documentation.
It is a synthetic seven-amino-acid peptide built from the ACTH(4-7) sequence plus a Pro-Gly-Pro tail. It belongs to the family of short ACTH fragments studied for nervous-system effects. Its backbone contains only standard amino acids.